Penta-acetyl Geniposide Suppresses Migration, Invasion, and Inflammation of TNF-α-Stimulated Rheumatoid Arthritis Fibroblast-Like Synoviocytes Involving Wnt/β-Catenin Signaling Pathway

Inflammation. 2021 Dec;44(6):2232-2245. doi: 10.1007/s10753-021-01495-y. Epub 2021 Jun 8.

Abstract

We previously reported that penta-acetyl geniposide ((Ac)5GP, an active derivative of geniposide) showed anti-arthritic effect on adjuvant-induced arthritis (AIA) rats by promoting the apoptosis of AIA fibroblast-like synoviocyte (FLS). This study aimed to demonstrate the effects of (Ac)5GP on migration, invasion, and inflammation of TNF-α-stimulated rheumatoid arthritis (RA) FLS (MH7A cell) and to explore the involved mechanisms. MTT assay was used to determine the applied non-cytotoxic doses of (Ac)5GP (12.5, 25, 50 μM) in vitro. Results of wound-healing, transwell, and phalloidin staining assays indicated that (Ac)5GP reduced the migration, invasion, and F-actin cytoskeletal reorganization of TNF-α-stimulated MH7A. Results of ELISA and western blot assays confirmed that (Ac)5GP reduced TNF-α-induced production of pro-inflammatory cytokines (like IL-1β, IL-6, IL-8) and matrix metalloproteinases (MMPs, such as MMP-2 and MMP-9). Moreover, (Ac)5GP inhibited TNF-α-induced activation of Wnt/β-catenin pathway, evidenced by reducing the protein levels of Wnt1, p-GSK-3β (Ser9), and β-catenin and preventing β-catenin nuclear translocation. Importantly, the combination of XAV939 (an inhibitor of Wnt/β-catenin) promoted the actions of (Ac)5GP on TNF-α-induced migration, invasion, and inflammation, further revealing the involvement of Wnt/β-catenin pathway underlying the therapeutic effects of (Ac)5GP on TNF-α-stimulated MH7A. In vivo, (Ac)5GP relieved the progression and severity of rat collagen-induced arthritis, related to reducing the levels of IL-1β, IL-6, IL-8, MMP-2, and MMP-9 as well as inhibiting Wnt/β-catenin pathway in synovial tissues. Collectively, (Ac)5GP could suppress TNF-α-induced migration, invasion, and inflammation in RA FLS involving Wnt/β-catenin pathway and (Ac)5GP might be as a candidate agent for RA treatment.

Keywords: Wnt/β-catenin signaling pathway; fibroblast-like synoviocyte; inflammation; migration; penta-acetyl geniposide; rheumatoid arthritis.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Antirheumatic Agents / pharmacology*
  • Arthritis, Experimental / immunology
  • Arthritis, Experimental / metabolism
  • Arthritis, Experimental / pathology
  • Arthritis, Experimental / prevention & control*
  • Arthritis, Rheumatoid / immunology
  • Arthritis, Rheumatoid / metabolism
  • Arthritis, Rheumatoid / pathology
  • Arthritis, Rheumatoid / prevention & control*
  • Cell Line
  • Cell Movement / drug effects*
  • Fibroblasts / drug effects*
  • Fibroblasts / immunology
  • Fibroblasts / metabolism
  • Fibroblasts / pathology
  • Humans
  • Inflammation Mediators / metabolism
  • Iridoid Glucosides / pharmacology*
  • Male
  • Matrix Metalloproteinases / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Synoviocytes / drug effects*
  • Synoviocytes / immunology
  • Synoviocytes / metabolism
  • Synoviocytes / pathology
  • Tumor Necrosis Factor-alpha / toxicity
  • Wnt Signaling Pathway / drug effects*

Substances

  • Anti-Inflammatory Agents
  • Antirheumatic Agents
  • Inflammation Mediators
  • Iridoid Glucosides
  • Tumor Necrosis Factor-alpha
  • pentaacetyl geniposide
  • Matrix Metalloproteinases